ACCC Labelling Fines
Definition
Non-compliant ingredient labelling during CPSA triggers ACCC investigations, fines, and mandatory recalls.
Key Findings
- Financial Impact: Fines up to $10 million AUD for corporations; $500,000 AUD for individuals; product recalls.
- Frequency: Per mislabelled batch or ACCC audit.
- Root Cause: Manual transcription errors in INCI lists and failure to verify formulations against labels.
Why This Matters
The Pitch: Personal Care Product manufacturers in Australia 🇦🇺 face $10M AUD fines for labelling failures in CPSA. Automation of ingredient disclosure ensures compliance.
Affected Stakeholders
Labelling Specialist, Quality Assurance, CPSA Assessor
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
AICIS Non-Compliance Fines
TGA SUSMP Violation Penalties
AICIS Assessment & Reporting Costs
CPSA Product Recall Costs
Cost of Poor Quality in Batch Production
Capacity Loss from Quality Rework
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence